Molecular Targeted Therapy

Il craniofaringioma

Salce N, Giovannelli E, Graziani V, Cozzolino M, Mazzatenta D, Zucchelli M, Marchetti F

2021/7 — pag. 467-469 — DOI

Craniopharyngioma (CP) is a rare epithelial low-grade tumour that develops in the sellar/suprasellar region of the brain, along the craniopharyngeal duct. It has a bimodal distribution and the first peak occurs in paediatric age almost exclusively co...

Rapida evoluzione di una istiocitosi a cellule di Langerhans cutanea isolata

Brusadelli C, Dell’Acqua F, Vendemini F, Ferrari GM, Corti P

2021/7 — pag. 197-200 — DOI

The paper reports the case of a three-month-old girl presenting with maculopapular lesions all over her scalp, trunk, axilla region and groin. One month earlier she had been diagnosed with LCH through skin biopsy for persisting maculopapular rash. No...

Il craniofaringioma

Salce N, Giovannelli E, Graziani V, Cozzolino M, Mazzatenta D, Zucchelli M, Marchetti F

2021/7 — pag. 210-216 — DOI

Craniopharyngioma (CP) is a rare epithelial low-grade tumour that develops in the sellar/suprasellar region of the brain, along the craniopharyngeal duct. It has a bimodal distribution and the first peak occurs in paediatric age almost exclusively co...

Medicina di precisione: miti e realtà

Amoroso S, Baldo F, Bettini L, Bossini B, Nucera S

2021/1 — pag. 18-24 — DOI

Precision medicine is an emerging framework to maximise therapeutic benefit by modifying individual patients’ treatment considering the variations in their demographic, genomic and environmental factors. The present review describes recent advances, ...

Oncologia pediatrica: dalla diagnosi alla terapia, presente e futuro (parte seconda)

P. Paolucci, I. Mariotti, E. Bigi, S. Schiavo, C. Cano

2009/3 — pag. 156-161

The objective of treatment for more than 70% of children with cancer outlines the successful routes built up by paediatric oncologists over the latest 40 years. In addition to the evolution of diagnostic routes reported in our former article, the sec...

I farmaci delle malattie infiammatorie croniche: dall’empirismo alla medicina molecolare

Giulia Gortani, Erica Valencic, Alberto Tommasini, Loredana Lepore

2007/6 — pag. 381-385

Chronic inflammatory diseases still represent a very dramatic problem in pediatric age. Therapeutic strategies are improving very quickly, but a complete control of disease progression is still a challenge. In a series of articles we try to address a...

Le citochine: da mediatori della flogosi a bersaglio della terapia

T. Not, E. Buratti, I. Berti, C. Trevisiol, E. Neri, A. Tommasini

1998/2 — pag. 103-107